Read more

April 24, 2023
31 min listen
Save

Conversation with Tom Frinzi, Warren Foust and Magda Michna about STAAR Surgical

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Hosts Jim Mazzo and John A. Hovanesian, MD, FACS, discuss the new leadership at STAAR Surgical with Tom Frinzi, president and CEO; Warren Foust, COO; and Magda Michna, PhD.

  • Welcome to the Eyeluminaries podcast :00
  • Review of episode 13 with Gil Kliman, MD :23
  • Review of episode 12, the Annual Drug Name Awards :52
  • Preview of episode 14 1:20
  • Tom Frinzi, president and CEO; Warren Foust, COO; and Magda Michna, PhD, introduction 1:28
  • Tom: What were the qualities and factors that made you choose Foust and Michna to join the STAAR Surgical team? 3:42
  • Magda: Why STAAR Surgical? 6:07
  • Magda: What can you do to help repair the relationship between STAAR Surgical and the FDA? And what do you hope to change at STAAR? 8:07
  • Warren and Magda: What’s the 100-day plan? 9:47
  • Tom: How does STAAR Surgical plan to make the ICL exciting for doctors and patients in the US? 13:17
  • Warren: How do you get physicians excited about the ICL? 16:26
  • Tom and Warren: How do you compete with other companies that have an advantage when it comes to selling STAAR’s technology? 18:20
  • What kind of impact would you like to have on STAAR Surgical 3 to 5 years from now? 23:14
  • STAAR Surgical and the Jonas Brothers 28:25
  • Wrap up and thank you, Tom, Warren and Magda 29:51
  • Preview of episode 15 30:04
  • Feedback, questions and guest suggestions at eyeluminaries@healio.com 31:00
  • Thanks for listening 31:36

John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California.

Warren Foust is the chief operating officer at STAAR Surgical.

Thomas Frinzi is the president and chief executive officer at STAAR Surgical.

Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/Chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA.

Magda Michna, PhD, is the chief clinical, regulatory and medical affairs officer at STAAR Surgical.

We’d love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on Twitter @DrHovanesian.

Sources/Disclosures

Collapse

Disclosures: Foust is the chief operating officer at STAAR Surgical. Frinzi is the president and chief executive officer at STAAR Surgical. Hovanesian consults widely in the ophthalmic field. Mazzo reports being an adviser for Zeiss, Bain Capital, Avellino Labs, CVC Capital, Anivive Lifesciences; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Lensgen, IanTech, Centricity Vision and Visus. Michna is the chief clinical, regulatory and medical affairs officer at STAAR Surgical.